^
    Apply
    A Dose Escalation Study of APR003 in Patients With Advanced Colorectal Cancer (CRC) With Malignant Liver Lesions (NCT04645797)
    Phase 1
    Apros Therapeutics, Inc
    Completed
    Last update posted :
    02/01/2023
    Initiation :
    01/20/2021
    Primary completion :
    01/09/2023
    Completion :
    01/09/2023
    MSI
    |
    MSI-H/dMMR
    |
    APR003